1253 0 Kommentare The Alliance for Regenerative Medicine Holds Fourth Annual Partnering Forum at the Meeting on the Mesa - October 7 and 8 - Seite 2

"Each year the Meeting on the Mesa has grown both in the number of participants and the caliber of presenters, and the conference has become an annual event for many of the leaders throughout the regenerative medicine and advanced therapies fields," said Geoff MacKay, President and Chief Executive Officer of Organogenesis Inc. and Chairman of ARM. "This year the Partnering Forum has expanded to include an emphasis not only on cell therapies, but also gene and gene-modified cell therapy technologies. This, like the recent formation of ARM's Gene Therapy Section, is a natural progression for the meeting as the advanced therapies sector expands."

In addition to the more than 10 panels throughout the three-day program, 50 cutting-edge companies seeking partners and investors will also present during the Partnering Forum. More than 700 one-on-one meetings will also be scheduled using the EBD Group's state-of-the-art partnering software. The Partnering Forum was developed by the Alliance for Regenerative Medicine (ARM) and the California Institute for Regenerative Medicine (CIRM) in 2011 and has grown its attendance by 70% over the past three years. Life Technologies Corporation, a Thermo Fisher Scientific Brand is the meeting's founding and platinum-level sponsor.

To learn more or to register for the 2014 Stem Cell Meeting on the Mesa please visit www.stemcellmeetingonthemesa.com. Registration is complimentary for investors and credentialed members of the media.

About The Alliance for Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine worldwide. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations. Prior to the formation of ARM in 2009, there was no advocacy organization operating in Washington, DC to specifically represent the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today, ARM has more than 175 members and is the leading global advocacy organization in this field. To learn more about ARM or to become a member, visit www.alliancerm.org.